We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+19.87%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
+$17.9M
Cap. Flow
+$6.34M
Cap. Flow %
5.37%
Top 10 Hldgs %
16.29%
Holding
285
New
33
Increased
176
Reduced
36
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 43.59%
2 Miscellaneous 16.64%
3 Technology 10.39%
4 Industrials 9.8%
5 Real Estate 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
51
Intuitive Surgical
ISRG
$130B
$696K 0.59%
1,750
AMPX icon
52
Amprius Technologies
AMPX
$1.44B
$693K 0.59%
50,000
-10,000
-17% -$179K
NUVL
53
DELISTED
Nuvalent
NUVL
$686K 0.58%
5,558
+901
+19% +$96.9K
ABVX
54
Abivax
ABVX
$10B
$685K 0.58%
5,141
+1,717
+50% +$194K
BBJP icon
55
JPMorgan BetaBuilders Japan ETF
BBJP
$19.6B
$685K 0.58%
9,091
+249
+3% +$18.4K
SYM icon
56
Symbotic
SYM
$5.58B
$674K 0.57%
15,000
+2,500
+20% +$127K
SNPS icon
57
Synopsys
SNPS
$75.5B
$669K 0.57%
1,500
+850
+131% +$400K
IONQ icon
58
IonQ
IONQ
$16B
$666K 0.56%
+12,500
New +$633K
EWA icon
59
iShares MSCI Australia ETF
EWA
$1.35B
$661K 0.56%
23,476
+1,319
+6% +$38.3K
SERV
60
Serve Robotics
SERV
$429M
$658K 0.56%
100,000
+25,000
+33% +$209K
SOUN icon
61
SoundHound AI
SOUN
$2.99B
$647K 0.55%
100,000
+25,000
+33% +$194K
EWTX icon
62
Edgewise Therapeutics
EWTX
$4.68B
$644K 0.55%
15,840
+225
+1% +$7.76K
RR icon
63
Richtech Robotics
RR
$394M
$633K 0.54%
300,000
+50,000
+20% +$121K
NRIX icon
64
Nurix Therapeutics
NRIX
$2.71B
$627K 0.53%
25,845
+274
+1% +$4.67K
SNY icon
65
Sanofi
SNY
$106B
$622K 0.53%
14,590
+208
+1% +$9.29K
ORKA
66
Oruka Therapeutics
ORKA
$6.13B
$622K 0.53%
6,531
-4,975
-43% -$331K
KYMR icon
67
Kymera Therapeutics
KYMR
$9.76B
$617K 0.52%
5,385
+43
+0.8% +$3.69K
IEI icon
68
iShares 3-7 Year Treasury Bond ETF
IEI
$17.6B
$612K 0.52%
5,214
-1,305
-20% -$154K
PDYN icon
69
Palladyne AI
PDYN
$282M
$608K 0.52%
100,000
AVAV icon
70
AeroVironment
AVAV
$7.35B
$603K 0.51%
3,651
+7
+0.2% +$1.25K
QBTS icon
71
D-Wave Quantum Inc
QBTS
$6.18B
$600K 0.51%
+25,000
New +$548K
SYRE icon
72
Spyre Therapeutics
SYRE
$7.85B
$592K 0.5%
6,670
+36
+0.5% +$2.63K
BNTX icon
73
BioNTech
BNTX
$26.1B
$583K 0.49%
6,266
+650
+12% +$61.2K
SIDU icon
74
Sidus Space
SIDU
$210M
$562K 0.48%
200,000
LUNR icon
75
Intuitive Machines
LUNR
$2.38B
$535K 0.45%
25,000
-10,000
-29% -$281K

Similar funds

AlphaCentric Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, AlphaCentric Advisors held 285 positions worth $118M, up 18% from $100M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AlphaCentric Advisors deployed $6.34M of net new capital in Q2 2026, opening 33 new positions and adding to 176 existing holdings. Its largest new stake was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.41M trimmed.

  • AlphaCentric Advisors's largest Q2 2026 buy was Invesco NASDAQ 100 ETF: 4,518 shares worth $1.37M.
  • AlphaCentric Advisors added most to Synopsys in Q2 2026, an estimated $400K increase.
  • AlphaCentric Advisors's biggest Q2 2026 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.41M.
  • AlphaCentric Advisors fully exited Whitestone REIT in Q2 2026, selling an estimated $460K.
  • AlphaCentric Advisors's ten largest holdings make up 16% of its $118M portfolio in Q2 2026.
  • AlphaCentric Advisors opened 33 new positions and closed 26 in Q2 2026.
  • AlphaCentric Advisors's portfolio value rose 18% quarter-over-quarter to $118M.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.